Julie Devalliere

Nanobiotix

BIOGRAPHY

Julie Devalliere is a Principal Scientist at Nanobiotix, a clinical-stage biotechnology company specializing in nanomedicine based in Paris, France. She has over ten years of experience at the interface of cell biology, drug delivery, and nanotechnology, with a strong focus on translational research.

Julie contributes to the preclinical development of nanoparticle-based therapies at Nanobiotix, including targeting strategies, mechanistic studies, and efficacy and safety assessments. She completed postdoctoral training at Yale University and Harvard Medical School before joining the company.